 | • レポートコード：MRC2312MG11477 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、72ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のインフルエンザワクチン市場規模と予測を収録しています。・世界のインフルエンザワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界のインフルエンザワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のインフルエンザワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「三価インフルエンザワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 インフルエンザワクチンのグローバル主要企業は、Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 BCHT、 Jiangsu GDK、 KM Biologicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、インフルエンザワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のインフルエンザワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界のインフルエンザワクチン市場：タイプ別市場シェア、2022年 ・三価インフルエンザワクチン、四価インフルエンザワクチン 世界のインフルエンザワクチン市場：用途別、2018年-2023年、2024年-2029年 世界のインフルエンザワクチン市場：用途別市場シェア、2022年 ・6ヶ月～3年、> 3年 世界のインフルエンザワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界のインフルエンザワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるインフルエンザワクチンのグローバル売上、2018年-2023年 ・主要企業におけるインフルエンザワクチンのグローバル売上シェア、2022年 ・主要企業におけるインフルエンザワクチンのグローバル販売量、2018年-2023年 ・主要企業におけるインフルエンザワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 BCHT、 Jiangsu GDK、 KM Biologics ************************************************************* ・調査・分析レポートの概要 インフルエンザワクチン市場の定義 市場セグメント 世界のインフルエンザワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のインフルエンザワクチン市場規模 世界のインフルエンザワクチン市場規模：2022年 VS 2029年 世界のインフルエンザワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのインフルエンザワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のインフルエンザワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：三価インフルエンザワクチン、四価インフルエンザワクチン インフルエンザワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：6ヶ月～3年、> 3年 インフルエンザワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別インフルエンザワクチン市場規模 2022年と2029年 地域別インフルエンザワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 BCHT、 Jiangsu GDK、 KM Biologics ... |
This research report provides a comprehensive analysis of the Vaccine for Influenza market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Vaccine for Influenza market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Vaccine for Influenza, challenges faced by the industry, and potential opportunities for market players.
The global Vaccine for Influenza market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Vaccine for Influenza market presents opportunities for various stakeholders, including 6 Months to 3 Years, > 3 Years. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Vaccine for Influenza market. Additionally, the growing consumer demand present avenues for market expansion.
The global Vaccine for Influenza market was valued at US$ 7384.9 million in 2022 and is projected to reach US$ 11280 million by 2029, at a CAGR of 5.8% during the forecast period.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
Key Features:
The research report on the Vaccine for Influenza market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Vaccine for Influenza market.
Market Overview: The report provides a comprehensive overview of the Vaccine for Influenza market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Vaccine for Influenza market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Vaccine for Influenza market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Vaccine for Influenza market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Vaccine for Influenza market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Vaccine for Influenza market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Vaccine for Influenza market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Vaccine for Influenza, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Vaccine for Influenza market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Vaccine for Influenza market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application
6 Months to 3 Years
> 3 Years
Global Vaccine for Influenza Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vaccine for Influenza, market overview.
Chapter 2: Global Vaccine for Influenza market size in revenue and volume.
Chapter 3: Detailed analysis of Vaccine for Influenza manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccine for Influenza in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Vaccine for Influenza capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Vaccine for Influenza Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccine for Influenza Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccine for Influenza Overall Market Size
2.1 Global Vaccine for Influenza Market Size: 2022 VS 2029
2.2 Global Vaccine for Influenza Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Vaccine for Influenza Sales: 2018-2029
3 Company Landscape
3.1 Top Vaccine for Influenza Players in Global Market
3.2 Top Global Vaccine for Influenza Companies Ranked by Revenue
3.3 Global Vaccine for Influenza Revenue by Companies
3.4 Global Vaccine for Influenza Sales by Companies
3.5 Global Vaccine for Influenza Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Vaccine for Influenza Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Vaccine for Influenza Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccine for Influenza Players in Global Market
3.8.1 List of Global Tier 1 Vaccine for Influenza Companies
3.8.2 List of Global Tier 2 and Tier 3 Vaccine for Influenza Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Vaccine for Influenza Market Size Markets, 2022 & 2029
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type – Global Vaccine for Influenza Revenue & Forecasts
4.2.1 By Type – Global Vaccine for Influenza Revenue, 2018-2023
4.2.2 By Type – Global Vaccine for Influenza Revenue, 2024-2029
4.2.3 By Type – Global Vaccine for Influenza Revenue Market Share, 2018-2029
4.3 By Type – Global Vaccine for Influenza Sales & Forecasts
4.3.1 By Type – Global Vaccine for Influenza Sales, 2018-2023
4.3.2 By Type – Global Vaccine for Influenza Sales, 2024-2029
4.3.3 By Type – Global Vaccine for Influenza Sales Market Share, 2018-2029
4.4 By Type – Global Vaccine for Influenza Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Vaccine for Influenza Market Size, 2022 & 2029
5.1.2 6 Months to 3 Years
5.1.3 > 3 Years
5.2 By Application – Global Vaccine for Influenza Revenue & Forecasts
5.2.1 By Application – Global Vaccine for Influenza Revenue, 2018-2023
5.2.2 By Application – Global Vaccine for Influenza Revenue, 2024-2029
5.2.3 By Application – Global Vaccine for Influenza Revenue Market Share, 2018-2029
5.3 By Application – Global Vaccine for Influenza Sales & Forecasts
5.3.1 By Application – Global Vaccine for Influenza Sales, 2018-2023
5.3.2 By Application – Global Vaccine for Influenza Sales, 2024-2029
5.3.3 By Application – Global Vaccine for Influenza Sales Market Share, 2018-2029
5.4 By Application – Global Vaccine for Influenza Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Vaccine for Influenza Market Size, 2022 & 2029
6.2 By Region – Global Vaccine for Influenza Revenue & Forecasts
6.2.1 By Region – Global Vaccine for Influenza Revenue, 2018-2023
6.2.2 By Region – Global Vaccine for Influenza Revenue, 2024-2029
6.2.3 By Region – Global Vaccine for Influenza Revenue Market Share, 2018-2029
6.3 By Region – Global Vaccine for Influenza Sales & Forecasts
6.3.1 By Region – Global Vaccine for Influenza Sales, 2018-2023
6.3.2 By Region – Global Vaccine for Influenza Sales, 2024-2029
6.3.3 By Region – Global Vaccine for Influenza Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Vaccine for Influenza Revenue, 2018-2029
6.4.2 By Country – North America Vaccine for Influenza Sales, 2018-2029
6.4.3 US Vaccine for Influenza Market Size, 2018-2029
6.4.4 Canada Vaccine for Influenza Market Size, 2018-2029
6.4.5 Mexico Vaccine for Influenza Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Vaccine for Influenza Revenue, 2018-2029
6.5.2 By Country – Europe Vaccine for Influenza Sales, 2018-2029
6.5.3 Germany Vaccine for Influenza Market Size, 2018-2029
6.5.4 France Vaccine for Influenza Market Size, 2018-2029
6.5.5 U.K. Vaccine for Influenza Market Size, 2018-2029
6.5.6 Italy Vaccine for Influenza Market Size, 2018-2029
6.5.7 Russia Vaccine for Influenza Market Size, 2018-2029
6.5.8 Nordic Countries Vaccine for Influenza Market Size, 2018-2029
6.5.9 Benelux Vaccine for Influenza Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Vaccine for Influenza Revenue, 2018-2029
6.6.2 By Region – Asia Vaccine for Influenza Sales, 2018-2029
6.6.3 China Vaccine for Influenza Market Size, 2018-2029
6.6.4 Japan Vaccine for Influenza Market Size, 2018-2029
6.6.5 South Korea Vaccine for Influenza Market Size, 2018-2029
6.6.6 Southeast Asia Vaccine for Influenza Market Size, 2018-2029
6.6.7 India Vaccine for Influenza Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Vaccine for Influenza Revenue, 2018-2029
6.7.2 By Country – South America Vaccine for Influenza Sales, 2018-2029
6.7.3 Brazil Vaccine for Influenza Market Size, 2018-2029
6.7.4 Argentina Vaccine for Influenza Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Vaccine for Influenza Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Vaccine for Influenza Sales, 2018-2029
6.8.3 Turkey Vaccine for Influenza Market Size, 2018-2029
6.8.4 Israel Vaccine for Influenza Market Size, 2018-2029
6.8.5 Saudi Arabia Vaccine for Influenza Market Size, 2018-2029
6.8.6 UAE Vaccine for Influenza Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Vaccine for Influenza Major Product Offerings
7.1.4 Sanofi Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Vaccine for Influenza Major Product Offerings
7.2.4 CSL Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.2.5 CSL Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Vaccine for Influenza Major Product Offerings
7.3.4 GSK Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Viatris
7.4.1 Viatris Company Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Vaccine for Influenza Major Product Offerings
7.4.4 Viatris Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.4.5 Viatris Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Vaccine for Influenza Major Product Offerings
7.5.4 AstraZeneca Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Hualan Bio
7.6.1 Hualan Bio Company Summary
7.6.2 Hualan Bio Business Overview
7.6.3 Hualan Bio Vaccine for Influenza Major Product Offerings
7.6.4 Hualan Bio Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.6.5 Hualan Bio Key News & Latest Developments
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Company Summary
7.7.2 Changchun Institute of Biological Business Overview
7.7.3 Changchun Institute of Biological Vaccine for Influenza Major Product Offerings
7.7.4 Changchun Institute of Biological Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.7.5 Changchun Institute of Biological Key News & Latest Developments
7.8 Sinovac
7.8.1 Sinovac Company Summary
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Vaccine for Influenza Major Product Offerings
7.8.4 Sinovac Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.8.5 Sinovac Key News & Latest Developments
7.9 BCHT
7.9.1 BCHT Company Summary
7.9.2 BCHT Business Overview
7.9.3 BCHT Vaccine for Influenza Major Product Offerings
7.9.4 BCHT Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.9.5 BCHT Key News & Latest Developments
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Company Summary
7.10.2 Jiangsu GDK Business Overview
7.10.3 Jiangsu GDK Vaccine for Influenza Major Product Offerings
7.10.4 Jiangsu GDK Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.10.5 Jiangsu GDK Key News & Latest Developments
7.11 KM Biologics
7.11.1 KM Biologics Company Summary
7.11.2 KM Biologics Business Overview
7.11.3 KM Biologics Vaccine for Influenza Major Product Offerings
7.11.4 KM Biologics Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.11.5 KM Biologics Key News & Latest Developments
8 Global Vaccine for Influenza Production Capacity, Analysis
8.1 Global Vaccine for Influenza Production Capacity, 2018-2029
8.2 Vaccine for Influenza Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccine for Influenza Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vaccine for Influenza Supply Chain Analysis
10.1 Vaccine for Influenza Industry Value Chain
10.2 Vaccine for Influenza Upstream Market
10.3 Vaccine for Influenza Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vaccine for Influenza Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
